Shufro Rose & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5M Sell
19,696
-186
-0.9% -$43.3K 0.29% 49
2026
Q1
$4.86M Sell
19,882
-4,375
-18% -$1.02M 0.33% 49
2025
Q4
$5.02M Sell
24,257
-828
-3% -$164K 0.34% 47
2025
Q3
$4.16M Sell
25,085
-70
-0.3% -$12K 0.34% 52
2025
Q2
$4.17M Sell
25,155
-1,604
-6% -$247K 0.34% 54
2025
Q1
$4.44M Sell
26,759
-686
-2% -$107K 0.35% 54
2024
Q4
$3.97M Sell
27,445
-673
-2% -$104K 0.31% 56
2024
Q3
$4.11M Hold
28,118
0.33% 57
2024
Q2
$4.11M Buy
28,118
+116
+0.4% +$17.3K 0.33% 57
2024
Q1
$4.43M Buy
28,002
+120
+0.4% +$19.1K 0.37% 52
2023
Q4
$4.34M Buy
27,882
+500
+2% +$76.7K 0.41% 51
2023
Q3
$4.26M Sell
27,382
-500
-2% -$82.5K 0.4% 51
2023
Q2
$4.62M Sell
27,882
-83
-0.3% -$13.4K 0.42% 47
2023
Q1
$4.33M Sell
27,965
-3,387
-11% -$547K 0.4% 50
2022
Q4
$5.54M Sell
31,352
-1,662
-5% -$287K 0.47% 53
2022
Q3
$5.39M Buy
33,014
+741
+2% +$125K 0.54% 43
2022
Q2
$5.73M Buy
32,273
+151
+0.5% +$26.9K 0.5% 45
2022
Q1
$5.69M Sell
32,122
-1,359
-4% -$231K 0.44% 52
2021
Q4
$5.73M Sell
33,481
-573
-2% -$93.8K 0.41% 50
2021
Q3
$5.5M Buy
34,054
+12,939
+61% +$2.21M 0.43% 51
2021
Q2
$3.48M Sell
21,115
-646
-3% -$107K 0.26% 57
2021
Q1
$3.58M Sell
21,761
-364
-2% -$58.9K 0.28% 56
2020
Q4
$3.48M Sell
22,125
-4,904
-18% -$724K 0.29% 57
2020
Q3
$4.02M Sell
27,029
-1,875
-6% -$277K 0.39% 51
2020
Q2
$4.07M Sell
28,904
-5,718
-17% -$833K 0.4% 50
2020
Q1
$4.54M Sell
34,622
-3,737
-10% -$530K 0.54% 45
2019
Q4
$5.59M Sell
38,359
-749
-2% -$102K 0.5% 45
2019
Q3
$5.06M Sell
39,108
-594
-1% -$78.3K 0.5% 48
2019
Q2
$5.53M Sell
39,702
-279
-0.7% -$38.6K 0.54% 47
2019
Q1
$5.59M Buy
39,981
+1,829
+5% +$245K 0.56% 49
2018
Q4
$4.92M Sell
38,152
-1,312
-3% -$183K 0.54% 50
2018
Q3
$5.45M Buy
39,464
+616
+2% +$81.9K 0.51% 56
2018
Q2
$4.71M Sell
38,848
-460
-1% -$57.4K 0.45% 64
2018
Q1
$5.04M Sell
39,308
-5
-0% -$676 0.5% 53
2017
Q4
$5.49M Sell
39,313
-786
-2% -$109K 0.54% 51
2017
Q3
$5.21M Hold
40,099
0.52% 54
2017
Q2
$5.3M Sell
40,099
-2,445
-6% -$312K 0.57% 52
2017
Q1
$5.3M Sell
42,544
-242
-0.6% -$28.9K 0.57% 47
2016
Q4
$4.93M Sell
42,786
-199
-0.5% -$23K 0.55% 48
2016
Q3
$5.08M Sell
42,985
-2,465
-5% -$299K 0.57% 51
2016
Q2
$5.51M Sell
45,450
-2,339
-5% -$266K 0.61% 56
2016
Q1
$5.17M Buy
47,789
+6,340
+15% +$656K 0.58% 56
2015
Q4
$4.26M Sell
41,449
-175
-0.4% -$17.6K 0.49% 59
2015
Q3
$3.88M Sell
41,624
-230
-0.5% -$22.2K 0.47% 58
2015
Q2
$4.08M Sell
41,854
-1,480
-3% -$148K 0.43% 61
2015
Q1
$4.36M Sell
43,334
-210
-0.5% -$21.4K 0.45% 63
2014
Q4
$4.55M Sell
43,544
-280
-0.6% -$29.5K 0.46% 64
2014
Q3
$4.67M Sell
43,824
-235
-0.5% -$24.4K 0.48% 63
2014
Q2
$4.61M Sell
44,059
-1,887
-4% -$191K 0.47% 63
2014
Q1
$4.51M Sell
45,946
-226
-0.5% -$21K 0.47% 61
2013
Q4
$4.23M Buy
46,172
+2,062
+5% +$190K 0.45% 60
2013
Q3
$3.82M Sell
44,110
-3,555
-7% -$319K 0.43% 63
2013
Q2
$4.09M Buy
+47,665
New +$4.04M 0.49% 57

Other funds holding JNJ

Shufro Rose & Co's JNJ Position: Q2 2026 in Review

Shufro Rose & Co reduced its Johnson & Johnson (JNJ) stake by 0.94% in Q2 2026, selling an estimated $43.3K and leaving 19,696 shares worth $5M. The position accounts for 0.29% of the portfolio, ranked #49.

Shufro Rose & Co first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.73M in Q2 2022. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Shufro Rose & Co held 19,696 shares of Johnson & Johnson worth $5M as of Q2 2026.
  • Shufro Rose & Co sold 186 Johnson & Johnson shares in Q2 2026, an estimated $43.3K.
  • Johnson & Johnson made up 0.29% of Shufro Rose & Co's portfolio in Q2 2026, its #49 holding.
  • Shufro Rose & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Shufro Rose & Co's Johnson & Johnson position peaked at $5.73M in Q2 2022.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Shufro Rose & Co's 13F filing for Q2 2026, filed 12 Aug 2026.